Table 2

Demographic and clinical data on 134 patients who received OPAT (145 treatment episodes), with bacteraemia and without bacteraemia

Without bacteraemiaWith bacteraemiap Value*
Patients11222
Episodes12322
Age† (years), n (%)0.777
 16–3020 (17.9)2 (9.1)
 31–5035 (31.3)7 (31.8)
 51–7035 (31.3)8 (36.4)
 >7022 (19.6)5 (22.7)
Gender†, n (%)0.701
 Male51 (45.5)12 (50.0)
 Female61 (54.5)11 (50.0)
Specialty, n (%)0.941
 Medical109 (88.6)19 (86.4)
 Surgical10 (8.1)2 (9.1)
 O&G4 (3.3)1 (4.6)
Site of infection, n (%)0.025
 Urinary tract (upper)26 (21.1)9 (40.9)
 Urinary tract (lower)14 (11.4)2‡ (9.1)
 Biliary tract02 (9.1)
 Skin and soft tissue57 (46.3)2 (9.1)
 Central venous catheter02 (9.1)
 GI tract2 (1.6)3 (13.6)
 Infective endocarditis01 (4.6)
 LRT1 (0.8)0
 Meninges2 (1.6)0
 Orthopaedic infections6 (4.9)1 (4.6)
  Vertebral column (VC)20
  Osteomyelitis (non-VC)00
  Peripheral joints31
  Sternal wound10
 Other15§ (12.2)0
Outcome†, n (%)0.987
 Recovered/anticipated outcome107 (95.5)21 (95.5)
 Relapse5 (4.5)1 (4.6)
Death within 30 days of treatment completion, N (%)00N/a
Duration of intravenous treatment (days)0.207
 Mean (SD)8.6 (9.5)6.2 (4.0)
 Median (max–min)7.0 (0.0–64.0)6.0 (0.0–14.0)
  • 2 test for categorical variables, t-test for continuous variables.

  • †Patient-specific variables so reported as a percentage of patients. One patient is in both columns because they had one episode without bacteraemia and one with bacteraemia.

  • ‡One postprostatic biopsy.

  • §Other included liver abscesses, malignant otitis externa, meningitis, leptospirosis, infected ovarian cysts, prepatella bursitis, fistula infection, tuberculosis, bronchiectasis and community-acquired pneumonia with empyema.

  • GI, gastrointestinal; LRT, lower respiratory tract; O&G, obstetrics and gynaecology; OPAT, outpatient parenteral antibiotic treatment.